Coxanto Capsule
Product Images NDC 70512-814

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Coxanto (NDC 70512-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemicalstructure)

FDA Label Image

Label (Label)

Label (Label)
This text provides important instructions for storing and dispensing capsules containing 300 mg of oxaprozin. It recommends storing the capsules at room temperature with excursions permitted within certain temperature ranges. The capsules should be protected from light and dispensed in tight, light-resistant, child-resistant containers. Additionally, it emphasizes the importance of dispensing with the Medication Guide. The product is made for SOLA Pharmaceuticals, LLC in Baton Rouge, LA.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.